Nanopharm
Cwmbran, United Kingdomnanopharm.co.ukFrom their website, Nov 2026
- GMP
Work here? Claim this listing
About
Nanopharm is a pharmaceutical CRO focused on developing orally inhaled and nasal drug products for small molecules and biologics. It supports customers with product development, analytical testing, in-silico modeling, regulatory consultancy, and clinical trial manufacturing services. The company is based in Cwmbran, United Kingdom, and operates as part of Aptar Pharma.
Services
Product Development
Develops nasal and inhaled drug products from preformulation and preclinical work through formulation and clinical development.
Preformulation & Preclinical
Studies drug substance properties, critical material attributes, excipients, solubility, stability, permeability, and preclinical models for OINDPs.
Spray Drying & Particle Engineering
Uses spray drying and particle engineering to control particle size, morphology, solubility, and other powder properties for OINDPs.
Formulation & Drug Product Development
Develops intranasal and inhaled formulations and combines formulation, device, and analytical studies to design complete drug products.
Clinical Development
Supports progression of OINDPs into clinical stages and commercialization with cGMP-oriented development services.
Clinical Trial Manufacturing
Provides clinical trial materials manufacturing support through Aptar Pharma Services' Boonton site for Phase 1 and 2 OINDP programs.
CDMO: development & manufacturing
cGMP Release & Stability Testing
Performs cGMP analytical release and stability testing for inhaled and intranasal drug products, including method development and validation.
Clinical Labeling
Provides open and blinded labeling of clinical supplies for clinical studies.
10 more services
- Analytical Services
- Research & Development
- Spray Characterization
- Method Development
- IVBE & CMC Studies
- Alternative Bioequivalence
- In-Silico Modeling
- PBPK Modeling
- Regional Deposition Modeling
- Regulatory Consultancy
Capabilities
- Assays and studies
- Stability studies
- PK/PD
- Small molecules
- Analytical development
- Spray pattern
- Plume geometry
17 more
- Particle size distribution
- Droplet size distribution
- Delivered dose uniformity
- Aerodynamic particle size distribution
- Single actuation content
- Dissolution
- Solubility testing
- Degradation pathway analysis
- Compatibility testing
- Pharmacokinetic simulation
- Analytical testing
- In-vitro testing
- In-silico modeling
- Stability testing
- Release testing
- Method development
- Spray characterization
- Scale and capacity
- 8L pilot scale mixing and filling line
- cGMP pilot scale
- Phase 1 and 2 cGMP fill and finish services
- cGMP cleanrooms
- Phase 1 and Phase 2 clinical trial manufacturing
- High-potency API suites
- Biologics capabilities
- Therapeutic areas
- Respiratory
- Nasal
- Central nervous system
Instruments and platforms
- Morphologically Directed Raman Spectroscopy (MDRS)
- Aeronose® Nasal CAST 3D
- SmartTrack™
- Simhalation
Modalities and species
- Modalities
- Small molecule
- Species and models
- Preclinical or animal models
- Human nasal cavity
- Lungs
Certifications
As the company states them, with the certificate or registry record where there is one.
GMPSelf-reported
Scope: analytical testing, release and stability testing, clinical development support
Company
- Type
- CRO
- Founded
- 2002
Locations
- Based in
- Cwmbran, United Kingdom
- Sites
- Boonton, United States · Boonton, New Jersey, United States
- Serves
- United Kingdom, United States, global
Contacts
- Phone
- +44 (0) 1633 372200